Scholars Central

Short communicationPublished 2020

A novel anti-CD20 monoclonal antibody shows favorable pharmacodynamic effects and acceptable safety profile in patients with multiple sclerosis

Authors: Maria Morozova

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases and Treatment Open Access
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Maria Morozova”